LEVI STRAUSS & CO — Director's Dealing 2019

Dec 12, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEVI STRAUSS & CO (LEVI)
CIK: 0000094845
Period of Report: 2019-12-10

Reporting Person: Ellison Seth M. (EVP & President, Europe)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-11	Class A Common Stock	C	8020	$0.00	Acquired	86180	Direct
2019-12-11	Class A Common Stock	S	8020	$17.97	Disposed	78160	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-10	Stock Appreciation Rights	$7.425	M	8210	Disposed	2022-02-04	Class B Common Stock (8210)	Direct
2019-12-10	Class B Common Stock	$	M	8210	Acquired		Class A Common Stock (8210)	Direct
2019-12-10	Class B Common Stock	$	D	5781	Disposed		Class A Common Stock (5781)	Direct
2019-12-10	Stock Appreciation Rights	$6.10	M	16790	Disposed	2023-02-09	Class B Common Stock (16790)	Direct
2019-12-10	Class B Common Stock	$	M	16790	Acquired		Class A Common Stock (16790)	Direct
2019-12-10	Class B Common Stock	$	D	11199	Disposed		Class A Common Stock (11199)	Direct
2019-12-11	Class B Common Stock	$	C	8020	Disposed		Class A Common Stock (8020)	Direct

Footnotes

F1: Transaction pursuant to a previously established Rule 10b5-1 Plan.

F2: Represents the conversion of Class B Common Stock into Class A Common Stock held of record by the Reporting Person.

F3: The price in Column 4 is a weighted average sale price. The prices actually received ranged from $17.87 to $18.03. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F4: 100% of these SARs are fully vested.

F5: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F6: Of these SARs: (i) 229,830 are performance stock appreciation rights (PSARs) that vested on January 30, 2019 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors, and are immediately exercisable; and (ii) 92,390 are time-based SARs from an original grant of 275,800 SARs, of which 183,410 have been exercised, that vested as to 25% of the SARs on February 9, 2017, with the remainder vesting in 36 equal monthly installments thereafter.